SG
ZOM

StoneX Group’s Zomedica Corp. ZOM Stock Holding History

StoneX Group’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-20,000
Closed -$2.4K – 1034
2024
Q4 		$2.4K Buy
+20,000
New +$2.52K ﹤0.01% 839
2022
Q1 		– Sell
-20,000
Closed -$6.13K – 691
2021
Q4 		$6.13K Hold
20,000
– – ﹤0.01% 574
2021
Q3 		$10K Hold
20,000
– – ﹤0.01% 466
2021
Q2 		$17K Hold
20,000
– – ﹤0.01% 471
2021
Q1 		$32K Buy
+20,000
New +$32.7K 0.01% 412

Other funds holding ZOM

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
PRTG
Post Resch Tallon Group Pittsford, New York $145M AUM 25.19% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $290M AUM 17.7% 1-Year Est. Return
PCIA
Prime Capital Investment Advisors Overland Park, Kansas $8.65B AUM 19.52% 1-Year Est. Return

StoneX Group's ZOM Position: Q1 2025 in Review

StoneX Group sold out of Zomedica Corp. (ZOM) in Q1 2025, closing a stake of 20,000 shares — an estimated $2.4K sold.

StoneX Group first reported a position in ZOM in Q1 2021 and held it in 5 quarters. The position peaked at $32K in Q1 2021. 23 funds tracked by Wall St. Rank hold ZOM as of Q1 2025.

  • StoneX Group reported no remaining Zomedica Corp. position as of Q1 2025 after selling out during the quarter.
  • StoneX Group sold 20,000 Zomedica Corp. shares in Q1 2025, an estimated $2.4K.
  • StoneX Group first reported a position in Zomedica Corp. in Q1 2021 and held it in 5 quarters.
  • StoneX Group's Zomedica Corp. position peaked at $32K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held Zomedica Corp. as of Q1 2025.

Based on StoneX Group's 13F filing for Q1 2025, filed 15 May 2025.